Detalhe da pesquisa
1.
Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential.
Immunity
; 54(7): 1543-1560.e6, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34004141
2.
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis.
J Neuroinflammation
; 21(1): 128, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745307
3.
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis.
Eur J Neurol
; 31(3): e16071, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37754770
4.
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model.
J Neurochem
; 166(3): 534-546, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37332201
5.
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
Neurobiol Dis
; 184: 106203, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336364
6.
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis.
Mult Scler
; 29(4-5): 512-520, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803228
7.
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis.
Mult Scler
; 29(11-12): 1383-1392, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698019
8.
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis.
Neurobiol Dis
; 172: 105817, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835361
9.
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.
Neuropathol Appl Neurobiol
; 48(2): e12765, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490928
10.
Decipher non-canonical SPAST splicing mutations with the help of functional assays in patients affected by spastic paraplegia 4 (SPG4).
Clin Genet
; 102(2): 155-156, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524423
11.
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis.
J Neurochem
; 159(5): 857-866, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547109
12.
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis.
Brain Behav Immun
; 98: 13-27, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391817
13.
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Eur J Neurol
; 28(4): 1299-1307, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33305459
14.
Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients.
J Immunol
; 203(7): 1753-1765, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462505
15.
Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington's disease.
Hum Mol Genet
; 27(14): 2490-2501, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29688337
16.
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.
Haematologica
; 105(8): 2056-2070, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31780628
17.
Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis.
Mult Scler
; 26(3): 304-311, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30730244
18.
Obesity worsens central inflammation and disability in multiple sclerosis.
Mult Scler
; 26(10): 1237-1246, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161863
19.
A novel POLR3A genotype leads to leukodystrophy type-7 in two siblings with unusually late age of onset.
BMC Neurol
; 20(1): 258, 2020 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600288
20.
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
Neurol Sci
; 41(10): 2905-2913, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335779